Keya Watkins, PMP
President, Oncology
Keya brings 30 years of experience in drug development with both biopharma and clinical service providers. She joined Worldwide in February 2026 as our President, Oncology following the merger of Catalyst Clinical Research where she served as the Senior Vice President of Catalyst Oncology responsible for the execution of the Oncology CRO Operations.
Ask Keya a question
Submit an RFP. Ask a Question
Keya has built and provided oversight of multidisciplinary teams across clinical development operations inclusive of clinical operations, data sciences and trial support services previously. She also served as an executive in both operational and commercial roles and has been involved in several complex, global trials in various therapeutic areas and phases with a concentration on oncology and hematology programs. Keya prides herself on building and managing high-functioning teams that deliver excellence while ultimately bringing meaningful therapies to patients in need.
Keya earned her degree from Temple University, Philadelphia, Pennsylvania, and maintains her certification as a Project Management Professional.
